Explain this page
Arphra AIPlain-English read on Onconetix, Inc.’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Peers
No peer list available for ONCO.
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -5.03% | -8.83% | -82.05% | -96.60% | -99.14% | -98.54% | -99.66% | -100.00% | -100.00% | -100.00% | -100.00% |
Aftermarket
LiveLast trade
$1.14
10 sh
Bid
$1.13
39 sh
Ask
$1.25
1 sh
Spread
$0.120
Sector & industry today
LiveSectors
- Technology+4.11%
- Basic Materials+1.08%
- Energy+0.87%
- Industrials+0.37%
- Consumer Cyclical+0.34%
- Communication Services+0.08%
- Utilities-0.27%
- Real Estate-0.63%
- Consumer Defensive-0.82%
- Financial Services-1.11%
- Healthcare-1.21%
Top industries (issuer's industry highlighted)
- Biotechnology-2.51%
- Computer Hardware+7.50%
- Software - Infrastructure+7.00%
- Coal+4.70%
- Semiconductors+4.59%
- Luxury Goods-4.44%
- Consulting Services+4.19%
- Staffing & Employment Services+4.08%
- Broadcasting+3.74%
- Copper+3.51%
- Medical - Equipment & Services+3.50%
- Electronic Gaming & Multimedia-3.39%
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_items- Onconetix Reports Q1 2026 Progress at Proteomedix AG, Including Two New Peer-Reviewed Publications and Initiation of U.S. Validation Studyglobenewswire.com·May 13, 2026
- Onconetix Reports Q1 2026 Progress at Proteomedix AG, Including Two New Peer-Reviewed Publications and Initiation of U.S. Validation Studyglobenewswire.com·May 13, 2026
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|